Early Access — free while we kick the tires
EdgarHawk

Murphy Sean

Chief Manuf, Strategy&Bus Dev.

Director Officer
1 filing analyzed · 1 company · Latest 2025-01-29

Companies

Company Buys Sells Direction
TriSalus Life Sciences, Inc. TLSI 3 0 Net buying

Activity

January 2025
high
Buy
30,000 shares
$157,200
Significance 6/10

Murphy (Chief Manuf, Strategy&Bus Dev.) bought 30,000 shares at blended $5.24 amid cluster buy; stock -52.3% from 52-week high

Sean Murphy, Chief Manufacturing, Strategy & Business Development officer, purchased 30,000 shares across two separate transactions on 2025-01-27 and 2025-01-28, totaling $157,200.00 at a blended average price of $5.24 per share. This purchase increased his holdings by 17.9% (from 167,732 to 197,732 shares) and occurs within a cluster pattern in which 2 other insiders also bought within the past 14 days. The stock is currently trading at $4.89, down 52.3% from its 52-week high of $10.25, despite posting strong annual revenue growth of 49.3%; however, the company remains unprofitable with net income of $-2,399,000.00 for the latest quarter. The convergence of multi-insider accumulation at depressed valuations, combined with operational growth but persistent losses, warrants investor attention to whether internal stakeholders believe the turnaround trajectory justifies entry at these price levels.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access